In a big study of more than 300,000 adults who were not on cholesterol-lowering drugs, having low 'bad' cholesterol was linked to fewer heart problems, but it was also linked to more kidney disease and a higher chance of dying from any cause during the study period.
See the scientific wording
In a large population-based cohort of over 300,000 adults not taking lipid-lowering medication, low levels of LDL cholesterol are associated with a decreased risk of atherosclerotic cardiovascular disease and an increased risk of chronic kidney disease and all-cause mortality.
Correlational — new studies may shift this
ObservationalOne moderate-quality study links this claim to the outcome, but causation is not established.
What the research says
1 study reviewedSupporting (1)
Cohort StudyHuman2023
The study found that naturally low bad cholesterol lowers heart disease risk but raises kidney disease risk, and it also seemed linked to higher death risk, but the stronger evidence shows the death link might not be directly caused by the low cholesterol.
Contradicting (0)
No contradicting studies found yet
That doesn't mean it's settled — it just means no study has tested the opposite.
Quality-weighted scoring: we follow the GRADE framework — each study is rated High, Moderate, Low, or Very Low based on study design, methodology rigor, and risk of bias. A single high-quality RCT can outweigh several weaker observational studies.
Scores reflect study quality, not just count.
Low LDL cholesterol is like a switch that turns down the process that clogs arteries, so heart disease risk goes down. But it also changes the amounts of other fats in the blood, like good cholesterol and triglycerides. These changes cause harm to the kidneys, making them work worse over time and raising the risk of kidney disease. So low LDL protects the heart but hurts the kidneys at the same time.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting study
How Fit Body Science checks a claim
- 1
We isolate the claim
Health advice from videos, articles and studies is broken down into single, testable claims.
- 2
We find the research
Each claim is matched against peer-reviewed studies, with every source cited by DOI.
- 3
We grade the evidence
Studies are scored on methodology, statistical rigor, transparency and publication quality.
The fitness and health internet is full of confident claims. We check them against real research.
Every claim on this site is traced back to peer-reviewed studies, scored on methodology and reporting quality, and given a verdict you can audit yourself — sources, DOIs and all.
- Full evidence breakdown and mechanism chains
- Ask our AI anything about a claim or its studies
- Get notified when new research changes a verdict
In a big study of more than 300,000 adults who were not on cholesterol-lowering drugs, having low 'bad' cholesterol was linked to fewer heart problems, but it was also linked to more kidney disease and a higher chance of dying from any cause during the study period.
Mechanism
1 studyLow LDL cholesterol protects the heart by keeping arteries from getting clogged. But it also messes with the levels of other fats in the blood, and those changes hurt the kidneys, making them work worse over time. So the same low LDL causes two opposite effects: good for the heart, bad for the kidneys.
Low LDL cholesterol is like a switch that turns down the process that clogs arteries, so heart disease risk goes down. But it also changes the amounts of other fats in the blood, like good cholesterol and triglycerides. These changes cause harm to the kidneys, making them work worse over time and raising the risk of kidney disease. So low LDL protects the heart but hurts the kidneys at the same time.
Low LDL cholesterol reduces the infiltration of LDL particles into arterial walls, decreasing the formation of atherosclerotic plaques and lowering the risk of cardiovascular events.
Low LDL cholesterol perturbs the balance of other lipid fractions, specifically lowering high-density lipoprotein (HDL) and altering triglyceride levels through shared metabolic pathways.
The altered HDL and triglyceride profile promotes lipotoxicity in kidney cells, leading to inflammation, oxidative stress, and fibrosis, which progressively impairs renal function and increases the risk of chronic kidney disease.
Evidence from Studies
Supporting (1)
Community contributions welcome
The study found that naturally low bad cholesterol lowers heart disease risk but raises kidney disease risk, and it also seemed linked to higher death risk, but the stronger evidence shows the death link might not be directly caused by the low cholesterol.
Contradicting (0)
Community contributions welcome
Score Breakdown
No multi-axis breakdown available yet. The overall Pro / Against score above is the best signal.
- No clinical evidence is available; the score reflects mechanistic plausibility only.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Systematic Review and Meta-Analysis of LDL Cholesterol Levels and Risk of ASCVD, CKD, and All-Cause Mortality in Adults Without Lipid-Lowering Medication
Comprehensive search of databases for prospective cohort studies involving adults not on lipid-lowering medication, with measured LDL cholesterol levels at baseline and follow-up for outcomes (ASCVD, CKD, mortality). Meta-analysis using random-effects models to pool hazard ratios.
Large Prospective Cohort Study of LDL Cholesterol and Incident ASCVD, CKD, and All-Cause Mortality in Adults Not on Lipid-Lowering Medication
Prospective cohort of adults aged 40-70 without lipid-lowering medication at baseline, measurement of LDL cholesterol, and follow-up for at least 10 years with adjudicated outcomes for ASCVD, CKD (e.g., eGFR decline), and all-cause mortality. Adjustment for confounders (age, sex, blood pressure, diabetes, etc.) and analysis using Cox proportional hazards models.
Case-Control Study of Low LDL Cholesterol and Risk of Chronic Kidney Disease and All-Cause Mortality
Population-based case-control: cases are adults with incident CKD or who died from any cause; controls are matched by age, sex, and other relevant factors. LDL cholesterol measured from stored blood samples or medical records prior to disease onset. Multivariable logistic regression to compute odds ratios.
Cross-Sectional Study of LDL Cholesterol Levels and Prevalence of Atherosclerotic Cardiovascular Disease and Chronic Kidney Disease
Survey of a representative adult population not on lipid-lowering medication, with LDL cholesterol measured and assessment of existing ASCVD and CKD (e.g., eGFR and albuminuria). Statistical analysis using logistic regression to estimate odds ratios.